• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number PED2-250-14
Medical Device Problem Codes Retraction Problem (1536); Physical Resistance/Sticking (4012)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/24/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Continuation of d10: product id unk-nv-fg15 (unknown); product type: ; implant date n/a; explant date n/a medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Medtronic received a report that the patient was undergoing treatment for a saccular, unruptured middle cerebral artery aneurysm with a max diameter of 3.4 mm and a 2.4 mm neck diameter.It was noted that the patient's vessel tortuosity was moderate.The landing zone was 2.5 mm distally and 2.45 mm proximally.It was unknown if dapt (dual antiplatelet treatment) was administered it was reported that during treatment, the initial distal end deployment was smooth.However, because adjustment of the distal anch oring position was required, the operator chose to recapture the stent and redeploy it.During this process, the distal end of the stent became stuck in the phenom 27 microcatheter.After multiple unsuccessful attempts, the entire system was withdrawn and replaced with another stent, after which the procedure was completed successfully.The angiographic result post procedure showed the vessel was patent.The pipeline was used for an indication that is approved (on-label).The reported device and any accessory devices were prepared as indicated in the instructions for use (ifu).No patient symptoms or complications were associated with this event.Ancillary devices include a navien guide catheter.
 
Additional Manufacturer Narrative
Updated b5, d9, h3: analysis results were not available at the time of this report.A follow-up will be sent once analysis is complete.H6: the evaluation codes have been updated for this event medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
Additional information was received.No causes or contributing factors were identified for the stent being stuck in the phenom.Resistance was reported at the tip end of the catheter.It could not be confirmed whether the stent became stuck in the phenom during resheathing.A continuous saline flush was administered and maintained in accordance with the ifu.No damage to the pipeline pushwire or catheter was observed.The phenom model and lot number were unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE FLEX W/SHIELD TECHNOLOGY
Common Device Name
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
MICRO THERAPEUTICS, INC. DBA EV3
9775 toledo way
irvine CA 92618
Manufacturer Contact
justin ellis
9775 toledo way
irvine, CA 92618
7635265677
MDR Report Key24701581
Report Number2029214-2026-00525
Device Sequence Number10557736
Product Code OUT
UDI-Device Identifier00763000448691
UDI-Public(01)00763000448691(17)280914(10)D065226
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
P100018
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 05/28/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberPED2-250-14
Device Catalogue NumberPED2-250-14
Device Lot NumberD065226
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/24/2026
Supplement Date Received by Manufacturer03/29/2026
05/01/2026
Initial Report FDA Received Date03/26/2026
Supplement Report FDA Received Date04/24/2026
05/28/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/15/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11...
Patient SexMale
-
-